Chen Han, Yu Rong-Guo, Yin Ning-Ning, Zhou Jian-Xin
Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.
Surgical Intensive Care Unit, Fujian Provincial Clinical College of Fujian Medical University, Fuzhou, 350001, Fujian, China.
Crit Care. 2014 Dec 8;18(6):675. doi: 10.1186/s13054-014-0675-x.
Extracorporeal membrane oxygenation (ECMO) is used in critically ill patients presenting acute cardiac and/or pulmonary dysfunctions, who are at high risk of developing acute kidney injury and fluid overload. Continuous renal replacement therapy (CRRT) is commonly used in intensive care units (ICU) to provide renal replacement and fluid management. We conducted a review to assess the feasibility, efficacy and safety of the combination of ECMO and CRRT and to illustrate the indications and methodology of providing renal replacement therapy during the ECMO procedure.
We searched for all published reports of a randomized controlled trial (RCT), quasi-RCT, or other comparative study design, conducted in patients undergoing ECMO plus CRRT. Two reviewers independently selected potential studies and extracted data. We used the modified Jadad scale and the Newcastle-Ottawa for quality assessment of RCTs and non-RCTs, respectively. Statistical analyses were performed using RevMan 5.2.
We identified 19 studies meeting the eligibility criteria (seven cohort, six case control, one historically controlled trial and five studies of technical aspects). There are three major methods for performing CRRT during ECMO: 'independent CRRT access', 'introduction of a hemofiltration filter into the ECMO circuit (in-line hemofilter)' and 'introduction of a CRRT device into the ECMO circuit'. We conducted a review with limited data synthesis rather than a formal meta-analysis because there could be greater heterogeneity in a systematic review of non-randomized studies than that of randomized trials. For ECMO survivors receiving CRRT, overall fluid balance was less than that in non-CRRT survivors. There was a higher mortality and a longer ECMO duration when CRRT was added, which may reflect a relatively higher severity of illness in patients who received ECMO plus CRRT.
The combination of ECMO and CRRT in a variety of methods appears to be a safe and effective technique that improves fluid balance and electrolyte disturbances. Prospective studies would be beneficial in determining the potential of this technique to improve the outcome in critically ill patients.
体外膜肺氧合(ECMO)用于患有急性心脏和/或肺功能障碍的危重症患者,这些患者发生急性肾损伤和液体超负荷的风险很高。连续性肾脏替代治疗(CRRT)常用于重症监护病房(ICU)以提供肾脏替代和液体管理。我们进行了一项综述,以评估ECMO与CRRT联合应用的可行性、有效性和安全性,并阐述在ECMO过程中提供肾脏替代治疗的适应证和方法。
我们检索了所有已发表的关于在接受ECMO加CRRT的患者中进行的随机对照试验(RCT)、半随机对照试验或其他比较研究设计的报告。两名评价者独立选择潜在研究并提取数据。我们分别使用改良的Jadad量表和纽卡斯尔-渥太华量表对RCT和非RCT进行质量评估。使用RevMan 5.2进行统计分析。
我们确定了19项符合纳入标准的研究(7项队列研究、6项病例对照研究、1项历史对照试验和5项技术方面的研究)。在ECMO期间进行CRRT有三种主要方法:“独立的CRRT通路”、“将血液滤过器引入ECMO回路(在线血液滤过器)”和“将CRRT设备引入ECMO回路”。我们进行了一项数据合成有限的综述,而不是正式的荟萃分析,因为对非随机研究的系统评价可能比随机试验具有更大的异质性。对于接受CRRT的ECMO幸存者,总体液体平衡低于未接受CRRT的幸存者。添加CRRT时死亡率更高,ECMO持续时间更长,这可能反映了接受ECMO加CRRT患者相对更高的疾病严重程度。
多种方法联合应用ECMO和CRRT似乎是一种安全有效的技术,可改善液体平衡和电解质紊乱。前瞻性研究将有助于确定该技术改善危重症患者预后的潜力。